KYN360
SELLAS Life Sciences shares plunge 19%: What triggered the sharp sell-off? - Visual Report
Share MarketEN

SELLAS Life Sciences shares plunge 19%: What triggered the sharp sell-off?

20 Nov 2026, 5:25 am2 min read55 reads
SELLAS Life Sciences shares plunged nearly 20% after the biotechnology company priced a $150 million public offering at $13 per share, a discount of around 28% to its previous close. The sell-off f...

SELLAS Life Sciences shares plunged nearly 20% after the biotechnology company priced a $150 million public offering at $13 per share, a discount of around 28% to its previous close. The sell-off f...

owed a sharp rally triggered by positive Phase 3 REGAL trial results for its experimental leukemia vaccine....

#KYN360News #AlwaysFirst

Stories matching key topics and tags in this report

More in Share Market

Coverage and updates from the Share Market section

View all

Latest News

Just-published stories and fresh reports across desks

View all

High-engagement stories capturing reader attention right now

Most Read

The most popular articles across all sections

Explore Other Categories

Selected reporting from across politics, business, tech, cinema, and world

Continue Reading

Hand-picked long reads and analysis for your next story